Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Survivin Antibody (32.1) - BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody has been used in 11 publications
Supplier: Novus Biologicals NB500237
Description
Survivin Monoclonal specifically detects Survivin in Human, Hamster samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin.Specifications
Survivin | |
Monoclonal | |
1.9 mg/mL | |
Western Blot 1:1000, Flow Cytometry, ELISA reported in scientific literature (PMID 11861764), Immunohistochemistry 20 ug/ml, Immunocytochemistry/Immunofluorescence 1:10-1:500, Immunoprecipitation reported in scientific literature (PMID 11861764), Immunohistochemistry-Paraffin 20 ug/ml | |
API4, apoptosis inhibitor 4, Apoptosis inhibitor survivin, baculoviral IAP repeat-containing 5, Baculoviral IAP Repeat-Containing Protein 5, BIRC5, EPR-1, IAP4, survivin variant 3 alpha | |
Mouse | |
16 kDa | |
0.1 mL | |
Adaptive Immunity, Angiogenesis, Apoptosis, Astrocyte Markers, Cancer, Growth and Development, Innate Immunity, Mitotic Regulators, Phospho Specific, Stem Cells | |
332 | |
Human, Hamster | |
Purified |
Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin) | |
32.1 | |
Unconjugated | |
O15392 | |
BIRC5 | |
This Survivin Antibody (32.1) was developed against full length recombinant human Survivin [UniProt# O15392] | |
Protein G purified | |
RUO | |
Primary | |
Survivin Antibody (32.1) [NB500-237] is specific for the nuclear form of survivin. | |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. | |
IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction